Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Weber

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Cancer Research|May 20, 2004
Microarray analysis reveals differences in gene expression of circulating CD8(+) T cells in melanoma patients and healthy donorsTong Xu, Chen-Tsen Shu, Elizabeth Purdom, et al.
Cancer Medicine|December 24, 2014
A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanomaRagini Kudchadkar, Scott Ernst, Bartosz Chmielowski, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2008
Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanomaJeffrey Weber, William Boswell, John Smith, et al.
Journal of Translational Medicine|February 18, 2021
Tumor immunogenomic signatures improve a prognostic model of melanoma survivalLeah Morales, Danny Simpson, Robert Ferguson, et al.
Plos One|April 6, 2013
Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapyJessica Ann Chacon, Richard C Wu, Pariya Sukhumalchandra, et al.
Journal for Immunotherapy of Cancer|April 19, 2020
C reactive protein impairs adaptive immunity in immune cells of patients with melanomaTatsuya Yoshida, Junya Ichikawa, Iulia Giuroiu, et al.
Cancer Research|September 4, 2012
Autophagy induced by conventional chemotherapy mediates tumor cell sensitivity to immunotherapyRupal Ramakrishnan, Chun Huang, Hyun-Il Cho, et al.
Journal of the National Cancer Institute|January 25, 2020
Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth EditionShirin Bajaj, Douglas Donnelly, Melissa Call, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2014
Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapyJessica Ann Chacon, Amod A Sarnaik, Jie Qing Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2004
Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanomaKristin Sanderson, Ronald Scotland, Peter Lee, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Cancer Research|May 20, 2004
Microarray analysis reveals differences in gene expression of circulating CD8(+) T cells in melanoma patients and healthy donorsTong Xu, Chen-Tsen Shu, Elizabeth Purdom, et al.
Cancer Medicine|December 24, 2014
A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanomaRagini Kudchadkar, Scott Ernst, Bartosz Chmielowski, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2008
Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanomaJeffrey Weber, William Boswell, John Smith, et al.
Journal of Translational Medicine|February 18, 2021
Tumor immunogenomic signatures improve a prognostic model of melanoma survivalLeah Morales, Danny Simpson, Robert Ferguson, et al.
Plos One|April 6, 2013
Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapyJessica Ann Chacon, Richard C Wu, Pariya Sukhumalchandra, et al.
Journal for Immunotherapy of Cancer|April 19, 2020
C reactive protein impairs adaptive immunity in immune cells of patients with melanomaTatsuya Yoshida, Junya Ichikawa, Iulia Giuroiu, et al.
Cancer Research|September 4, 2012
Autophagy induced by conventional chemotherapy mediates tumor cell sensitivity to immunotherapyRupal Ramakrishnan, Chun Huang, Hyun-Il Cho, et al.
Journal of the National Cancer Institute|January 25, 2020
Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth EditionShirin Bajaj, Douglas Donnelly, Melissa Call, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2014
Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapyJessica Ann Chacon, Amod A Sarnaik, Jie Qing Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2004
Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanomaKristin Sanderson, Ronald Scotland, Peter Lee, et al.
Pageof 11